Recently added articles from BIOTECH Patent News:
Hospital Approved Residential Water Features Kill Harmful Airborne Bacteria.(Accents In Water is a division of Kloppenberg and Co.)
Apr 01, 2009 ... It first began as an idea to fight airborne germs and bacteria in hospitals and healthcare settings, and in fact, Accents in Water (Denver, CO) remains the only Hospital-Approved, clinically tested water features available in the world today. Then, general public settings like restaurants, ...
Star Scientific Reports on Filing Patent Application for Zero-Nitrosamine Tobacco Curing Process, Product Development by Rock Creek Pharmaceuticals.
Apr 01, 2009 ... Star Scientific (Petersburg, VA) and its wholly-owned subsidiary, Rock Creek Pharmaceuticals, reported on their continuing efforts to lessen the harm linked with tobacco use. Star Scientific, through its CEO Jonnie R. Williams, recently filed a new US Patent Application for a novel ...
GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company.(Company overview)
Apr 01, 2009 ... GlaxoSmithKline plc (London, United Kingdom) and Pfizer, Inc (New York, NY) announced they have entered into an agreement to create a new world-leading HIV company focused solely on research, development and commercialisation of HIV medicines. The new HIV business will be more sustainable ...
Rib-X Granted Key Antibiotic Patent in China.
Apr 01, 2009 ... Rib-X Pharmaceuticals, Inc. (New Haven, CT), a development-stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic-resistant infections, announced the issuance of a key antibiotic patent in China. The State Intellectual Property Office of ...
Prometheus and Rosetta Genomics Announce License and Collaboration Agreement.
Apr 01, 2009 ... Prometheus Laboratories Inc. (San Diego, CA), a specialty pharmaceutical and diagnostic company, and Rosetta Genomics Ltd. (Rehovot, Israel), an innovative molecular diagnostic company, announced the execution of a license and collaboration agreement under which Rosetta shall grant ...